Difference between revisions of "Part:BBa K861072:Experience"
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
This experience page is provided so that any user may enter their experience using this part.<BR>Please enter | This experience page is provided so that any user may enter their experience using this part.<BR>Please enter | ||
Line 13: | Line 12: | ||
|width='10%'| | |width='10%'| | ||
<partinfo>BBa_K861072 AddReview number</partinfo> | <partinfo>BBa_K861072 AddReview number</partinfo> | ||
− | <I> | + | <I>iGEM2012 WHU-China</I> |
|width='60%' valign='top'| | |width='60%' valign='top'| | ||
− | + | [[Image:AdrA.jpg|500 px|center]] | |
+ | |||
+ | As can be seen from the plate. Clone with AdrA constitutively expressed using BBa_J23107 is much more smaller compared to the control that only contain the plasmids of RBS. This result showed that the AdrA was successfully expressed leading to the increase expression of adhesins and inhibition of motility. | ||
|}; | |}; | ||
<!-- End of the user review template --> | <!-- End of the user review template --> | ||
<!-- DON'T DELETE --><partinfo>BBa_K861072 EndReviews</partinfo> | <!-- DON'T DELETE --><partinfo>BBa_K861072 EndReviews</partinfo> |
Revision as of 20:24, 26 September 2012
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_K861072
User Reviews
UNIQ9e906e4125f6b6ce-partinfo-00000000-QINU UNIQ9e906e4125f6b6ce-partinfo-00000001-QINU